Physician profile
Annalee Knowles
NPI 1114594223
$1,391.28
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $790 · 2022: $574 · 2023: $26.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $350.08 | 2021-2022 | |
| Amgen INC. | $148.16 | 2021 | |
| Horizon Therapeutics Plc | $127.70 | 2021 | |
| Vifor Pharma, INC. | $120.08 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $86.87 | 2021-2022 | |
| Daiichi Sankyo INC. | $85.15 | 2021-2023 | Injectafer |
| Mallinckrodt Hospital Products INC. | $76.87 | 2022 | |
| Opko Pharmaceuticals, LLC | $74.28 | 2021-2022 | |
| Nuwellis, INC. | $56.40 | 2022 | |
| Aurinia Pharma U.S., INC. | $49.19 | 2021 | |
| Glaxosmithkline, LLC. | $48.58 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $39.11 | 2021 | |
| Akebia Therapeutics INC | $37.94 | 2021 | |
| Baxter Healthcare | $26.61 | 2022 | |
| Alnylam Pharmaceuticals INC. | $22.48 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.96 | 2021 | |
| Fresenius USA Marketing, INC. | $12.95 | 2022 | |
| Abbvie INC. | $12.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annalee Knowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.